ALTUVIIIO

Serial Number 90626528
Registration 7151486
700

Registration Progress

Application Filed
Apr 6, 2021
Under Examination
Jan 25, 2022
Approved for Publication
Nov 30, 2021
Published for Opposition
Nov 30, 2021
Registered
Aug 29, 2023

Trademark Image

ALTUVIIIO

Basic Information

Serial Number
90626528
Registration Number
7151486
Filing Date
April 6, 2021
Registration Date
August 29, 2023
Published for Opposition
November 30, 2021
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 29, 2023
Registration
Registered
Classes
005

Rights Holder

Bioverativ Therapeutics Inc.

03
Address
225 Second Avenue
Waltham, MA 02451

Ownership History

Bioverativ Therapeutics Inc.

Original Applicant
03
Waltham, MA

Bioverativ Therapeutics Inc.

Owner at Publication
03
Waltham, MA

Bioverativ Therapeutics Inc.

Original Registrant
03
Waltham, MA

Legal Representation

Attorney
Karen Lim

USPTO Deadlines

Next Deadline
1488 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-08-29)
Due Date
August 29, 2029
Grace Period Ends
February 28, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

27 events
Date Code Type Description Documents
Aug 29, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Aug 29, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 25, 2023 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jul 24, 2023 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jul 3, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jul 3, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jun 6, 2023 IUAF S USE AMENDMENT FILED Loading...
Jun 6, 2023 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Dec 14, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 12, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Dec 12, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Dec 12, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 13, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 11, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 11, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 11, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 25, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 30, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 30, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 10, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 28, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 26, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 14, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 29, 2021 AMPX O PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Loading...
Jun 23, 2021 ALIE A ASSIGNED TO LIE Loading...
Apr 12, 2021 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Apr 9, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical products for the prevention and treatment of blood disorders; pharmaceutical products for the prevention and treatment of hemophilia; pharmaceutical products for the prevention and treatment of immunological diseases
First Use Anywhere: Mar 27, 2023
First Use in Commerce: Mar 27, 2023

Classification

International Classes
005